Sustained Remission in Patients With Rheumatoid Arthritis Receiving Triple Therapy Compared to Biologic Therapy: A Swedish Nationwide Register Study

Study (n=1155 biologics [BL]; 347 triple therapy [TT] after inadequate response to methotrexate) found similar effectiveness for achieving short and long‐term sustained remission among patients who continued to receive BL or TT at 1 year and 2 years from treatment start.

Source:

Arthritis & Rheumatology